![Griet Nuytinck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Griet Nuytinck
Amministratore Delegato presso Post Verba Verbera NV
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Olivier Lemaire | M | - |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
Daniel Vuijlsteke | M | - |
Muziekcentrum De Bijloke Gent
| - |
Christian Cardon | M | 56 |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | 5 anni |
Margareta Nuytinck | F | - |
Post Verba Verbera NV
![]() Post Verba Verbera NV Medical/Nursing ServicesHealth Services Post Verba Verbera NV, also known as Anacura, is an independent analytical laboratory that operates in the healthcare and life sciences industry. The private company is based in Evergem, Belgium, and has subsidiaries in Belgium. The Belgian company provides high-quality analytical solutions with a personalized approach. The company was founded in 1998, and Margareta Nuytinck has been the CEO of the company since 2021. | 3 anni |
Marina Hoornaert | F | - |
Muziekcentrum De Bijloke Gent
| - |
Paco Collumbien | M | - |
Muziekcentrum De Bijloke Gent
| - |
Emiel van Camp | M | - |
Post Verba Verbera NV
![]() Post Verba Verbera NV Medical/Nursing ServicesHealth Services Post Verba Verbera NV, also known as Anacura, is an independent analytical laboratory that operates in the healthcare and life sciences industry. The private company is based in Evergem, Belgium, and has subsidiaries in Belgium. The Belgian company provides high-quality analytical solutions with a personalized approach. The company was founded in 1998, and Margareta Nuytinck has been the CEO of the company since 2021. | 3 anni |
Daan Schalck | M | - |
Muziekcentrum De Bijloke Gent
| - |
Karlijn Deene | F | - |
Muziekcentrum De Bijloke Gent
| - |
Johan Deckmyn | M | - |
Muziekcentrum De Bijloke Gent
| - |
Annie Vereecken | F | - |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
Fourat Ben Chikha | M | - |
Muziekcentrum De Bijloke Gent
| - |
Frank Beke | M | - |
Muziekcentrum De Bijloke Gent
| - |
Johan Van Hoof | M | - |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
Tom Almey | M | - |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
Bart Vandesompele | M | - |
Muziekcentrum De Bijloke Gent
| - |
Hilde Allaert | M | - |
Muziekcentrum De Bijloke Gent
| - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Belgio | 17 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Griet Nuytinck
- Contatti personali